[Pharmacological profile of human-type anti-CD20 antibody ofatumumab (Arzerra(®)) and its clinical study results]. [electronic resource]
Producer: 20140407Description: 40-3 p. digitalISSN:- 0015-5691
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibody-Dependent Cell Cytotoxicity -- drug effects
- Antigens, CD20 -- immunology
- Antineoplastic Agents -- administration & dosage
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Complement System Proteins -- immunology
- Disease Models, Animal
- Humans
- Japan
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Republic of Korea
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.